Director John Philip Coghlan filed a Form 4 with the SEC on November 4, 2026, disclosing the sale of 4,000 shares of Life360, Inc. common stock on November 2, 2026, executed under a pre-arranged Rule 10b5-1 trading plan.

Key Highlights

  • Reporting person: John Philip Coghlan, identified as a Director of Life360, Inc. (NASDAQ:LIF).
  • Shares sold: Three separate dispositions totaling 4,000 shares (1,841 + 1,433 + 726) from the John Coghlan Living Trust on November 2, 2026.
  • Sale prices: Weighted average prices of $45.29, $46.00, and $46.69 per share, with individual transactions ranging from $44.52 to $46.75 per share across all three tranches.
  • Post-transaction indirect holdings: 8,431 shares held indirectly by the John Coghlan Living Trust following the sales.
  • Additional indirect holdings: 55,494 shares held indirectly by The John Philip Coghlan 2025 Grantor Retained Annuity Trust, with no transactions reported for that account.
  • Direct holdings: 5,676 shares held directly, including 3,630 restricted stock units, each representing a contingent right to receive one share upon vesting.
  • Trading plan: All three sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Coghlan on December 8, 2025.

Coghlan's November 2 Sales Under 10b5-1 Plan

According to the filing, Coghlan disposed of 1,841 shares at a weighted average price of $45.29 (ranging from $44.52 to $45.51 per share), 1,433 shares at a weighted average price of $46.00 (ranging from $45.54 to $46.47 per share), and 726 shares at a weighted average price of $46.69 (ranging from $46.54 to $46.75 per share). All three transactions were coded "S" and were dispositions from the John Coghlan Living Trust, an indirect ownership vehicle.

The filing states that all sales were made pursuant to a Rule 10b5-1 trading plan adopted on December 8, 2025. The filing notes the plan is "a pre-arranged written trading plan pursuant to which shares of the Issuer's common stock are sold automatically based on a predetermined formula that was established by the Reporting Person at a time when the Reporting Person was not aware of any material nonpublic information about the Company." Coghlan has undertaken to provide full details of shares sold at each separate price within each range upon request by the issuer, any securityholder, or the SEC Staff.

Following the reported transactions, the filing shows Coghlan's indirect beneficial ownership in the John Coghlan Living Trust stood at 8,431 shares. Separately, 55,494 shares are held indirectly through The John Philip Coghlan 2025 Grantor Retained Annuity Trust, with no transactions reported for that trust. Direct holdings are reported as 5,676 shares, which the filing notes includes 3,630 restricted stock units representing contingent rights to receive one share each upon vesting. The form was signed by Jay Sood as Attorney-in-Fact on November 4, 2026.

What Was Disclosed

Life360 director John Philip Coghlan reported the sale of 4,000 shares of common stock on November 2, 2026, across three price tranches, all under a Rule 10b5-1 plan adopted December 8, 2025, with remaining indirect and direct holdings also disclosed.